LGALS3 and asthma: As indicated in studies above and this study, TH17 cells may be important mediators of lung tissue inflammation and contribute to the lung pathophysiological processes that contribute to asthma progression, and Gal-3 may affect the IL-17 expression profile in asthma [29–31].